Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate in Early Chikungunya Arthritis
NCT03058471Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Dec 2016
- Primary completion
- Oct 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of methotrexate in chikungunya fever (CHIKV) (2 arms), sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoint: Proportion of patients achieving remission at 6 months. Started Dec 2016; status: completed.
02
Drugs
methotrexate
03
Conditions
chikungunya fever (CHIKV)
Beyond the preview
Go deeper on NCT03058471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03058471.